QBFM
GHDX

QS Batterymarch Financial Management’s Genomic Health, Inc. GHDX Stock Holding History

QS Batterymarch Financial Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-5,300
Closed -$169K – 1161
2013
Q2 		$169K Buy
+5,300
New +$174K ﹤0.01% 904

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

QS Batterymarch Financial Management's GHDX Position: Q3 2013 in Review

QS Batterymarch Financial Management sold out of Genomic Health, Inc. (GHDX) in Q3 2013, closing a stake of 5,300 shares — an estimated $169K sold.

QS Batterymarch Financial Management first reported a position in GHDX in Q2 2013 and held it in 1 quarter. The position peaked at $169K in Q2 2013. 111 funds tracked by Wall St. Rank hold GHDX as of Q3 2013.

  • QS Batterymarch Financial Management reported no remaining Genomic Health, Inc. position as of Q3 2013 after selling out during the quarter.
  • QS Batterymarch Financial Management sold 5,300 Genomic Health, Inc. shares in Q3 2013, an estimated $169K.
  • QS Batterymarch Financial Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 1 quarter.
  • QS Batterymarch Financial Management's Genomic Health, Inc. position peaked at $169K in Q2 2013.
  • 111 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2013.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2013, filed 14 Nov 2013.